A phase II trial of ATX 201 in patients with actinic keratosis.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2007
At a glance
- Drugs ATX 201 (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- Sponsors Kythera Biopharmaceuticals
- 02 Jul 2007 New trial record.